Oscotec discovers bone growth compound

Oscotec Inc., a bone specialized biotech company based in Korea, says it has discovered a promising drug candidate to facilitate the bone growth under a two-year joint research with Harvard Medical School’s Institute of Chemistry and Cell Biology (ICCB), heralding a new breakthrough in osteoporosis.

According to the company, the new drug candidate targets Wnt proteins whose signaling pathway...